We are live on
!
Find out more
Antipodes Partners Portfolio holdings
AUM
$5.46B
Turnover
36.94%
1-Year Est. Return
26.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.16%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$5.46B
AUM Growth
+$264M
(+5.1%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
157
New
31
Increased
42
Reduced
55
Closed
27
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
2
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$90.4M |
| 2 |
Qorvo
QRVO
|
+$75.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$52.4M |
| 4 |
NVIDIA
NVDA
|
+$45.8M |
| 5 |
Capital One
COF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$59M |
| 2 |
Microsoft
MSFT
|
+$55.4M |
| 3 |
Amazon
AMZN
|
+$50.3M |
| 4 |
Merck
MRK
|
+$40.2M |
| 5 |
Oracle
ORCL
|
+$31.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 27.87% |
| 2 | Technology | 14.3% |
| 3 | Healthcare | 11.52% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Energy | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Tango Therapeutics
TNGX
$3.83B
| $32.4K | ﹤0.01% |
1,037
-585
| -36% | -$14.5K |
2025 Q4
2 quarters
|
|
127
Adlai Nortye Group ADS
ANL
$779M
| $18.9K | ﹤0.01% |
1,642
-409
| -20% | -$4.98K |
2026 Q1
1 quarter
|
|
128
Relmada Therapeutics
RLMD
$341M
| $16.7K | ﹤0.01% |
2,414
-621
| -20% | -$4.34K |
2026 Q1
1 quarter
|
|
129
DELISTED
AtaiBeckley Inc
ATAI
| $9.74K | ﹤0.01% |
1,849
-5,680
| -75% | -$23.9K |
2025 Q4
2 quarters
|
|
130
Sociedad Química y Minera de Chile
SQM
$17.3B
| $8.81K | ﹤0.01% |
119
-63
| -35% | -$5.28K |
2025 Q2
4 quarters
|
|
131
Alcon
ALC
$32.2B
| – | – |
-26,559
| Closed | -$1.96M | – |
|
132
AutoZone
AZO
$49.5B
| – | – |
-640
| Closed | -$2.16M | – |
|
133
Boston Scientific
BSX
$64B
| – | – |
-1,128
| Closed | -$70.8K | – |
|
134
Cabaletta Bio
CABA
$263M
| – | – |
-5,616
| Closed | -$15.1K | – |
|
135
Clipper Realty
CLPR
$51.5M
| – | – |
-125,668
| Closed | -$380K | – |
|
136
Americold
COLD
$3.97B
| – | – |
-1,159,803
| Closed | -$13.3M | – |
|
137
DexCom
DXCM
$33.1B
| – | – |
-554
| Closed | -$34.8K | – |
|
138
Gilead Sciences
GILD
$195B
| – | – |
-557
| Closed | -$77.6K | – |
|
139
IDEAYA Biosciences
IDYA
$3.27B
| – | – |
-917
| Closed | -$30.6K | – |
|
140
Disc Medicine
IRON
$2.17B
| – | – |
-476
| Closed | -$30.4K | – |
|
141
iRhythm Holdings
IRTC
$3.6B
| – | – |
-655
| Closed | -$77.3K | – |
|
142
CALL
KraneShares CSI China Internet ETF
KWEB
$4.48B
| – | – |
-2,206
| Closed | -$48.5K | – |
|
143
LSB Industries
LXU
$753M
| – | – |
-101,927
| Closed | -$1.52M | – |
|
144
LegalZoom.com
LZ
$1.06B
| – | – |
-80,268
| Closed | -$455K | – |
|
145
DELISTED
Nuvalent
NUVL
| – | – |
-275
| Closed | -$28.2K | – |
|
|
146
Oracle
ORCL
$408B
| – | – |
-212,117
| Closed | -$31.2M | – |
|
147
Oric Pharmaceuticals
ORIC
$1.32B
| – | – |
-1,278
| Closed | -$16.2K | – |
|
148
Otis Worldwide
OTIS
$26.8B
| – | – |
-61,687
| Closed | -$4.75M | – |
|
149
Regeneron Pharmaceuticals
REGN
$82B
| – | – |
-97
| Closed | -$74.9K | – |
|
150
StoneCo
STNE
$2.62B
| – | – |
-45,575
| Closed | -$644K | – |
|
Similar funds
SCM
Antipodes Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Antipodes Partners held 157 positions worth $5.46B, up 5.1% from $5.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Antipodes Partners's Q2 2026 filing shows 31 new, 42 increased, 55 reduced and 27 closed positions. Its largest new stake was Booking.com: 530,062 shares worth $94.2M. The largest sale was Workday, an estimated $59M.
By sector, the portfolio is most concentrated in Utilities at 28% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
- Antipodes Partners's largest Q2 2026 buy was Booking.com: 530,062 shares worth $94.2M.
- Antipodes Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $52.4M increase.
- Antipodes Partners's biggest Q2 2026 reduction was Workday, cutting an estimated $59M.
- Antipodes Partners fully exited Oracle in Q2 2026, selling an estimated $31.2M.
- Antipodes Partners's ten largest holdings make up 34% of its $5.46B portfolio in Q2 2026.
- Antipodes Partners opened 31 new positions and closed 27 in Q2 2026.
- Antipodes Partners's portfolio value rose 5.1% quarter-over-quarter to $5.46B.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.